Investigation of Methylation of EGFR in the Response of the Cetuximab in Metastatic Colorectal Cancer Patients

Plain-language summary

This study investigated the relationship between response to Cetuximab therapy and methylation of the EGFR gene in patients with metastatic colorectal cancer. It included patients with stage IV colon cancer. The study was carried out as a non-phase study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

N/A

Status

Completed

Sponsor

National Taiwan University Hospital

Start date

1/1/2014

Estimated completion

1/1/2016

Countries

Taiwan

Related genes

Locations

• Taipei, Taiwan

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* Colon cancer stage IV

Exclusion Criteria:

* Age under 20 years old and over 80 years old Patient didn't have surgery in NTUH